An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

This pilot study provides essential insights into how AI can augment traditional clinical workflows in diabetes management by ...

Diabetes, especially type 2 diabetes, is often referred to as a “silent epidemic” because it can develop slowly without ...

LuxIA, an AI algorithm co-developed by RetinAI US and ... as a Class IIb medical device in the European Union (EU) for diabetic retinopathy (DR) screening. Granted under the EU Medical Device ...

BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA ®, their co-developed innovative AI ...